Gough I R, Balderson G A
Department of Surgery, Royal Brisbane Hospital, Australia.
Cancer. 1993 Apr 1;71(7):2377-82. doi: 10.1002/1097-0142(19930401)71:7<2377::aid-cncr2820710732>3.0.co;2-h.
Effective palliation of malignant ascites remains a difficult management problem.
Eighty-five patients with malignant ascites were studied. Forty-two patients had peritoneovenous shunts (PVS) inserted (16 LeVeen, 17 single-valve Denver, 9 double-valve Denver).
Shunt patency was not related to the type of shunt, type of cancer, or any characteristic of the ascitic fluid. Ascites was controlled in 64% of patients with shunts and serum albumin levels were preserved. Survival and quality of life were not significantly different in comparison with those of patients treated by abdominal paracentesis.
PVS allowed many patients to be treated successfully outside the hospital and are indicated in carefully selected cases.
有效缓解恶性腹水仍然是一个棘手的管理问题。
对85例恶性腹水患者进行了研究。42例患者插入了腹腔静脉分流术(PVS)(16例LeVeen分流术、17例单瓣Denver分流术、9例双瓣Denver分流术)。
分流管通畅与分流类型、癌症类型或腹水的任何特征均无关。64%接受分流术的患者腹水得到控制,血清白蛋白水平得以维持。与接受腹腔穿刺术治疗的患者相比,其生存率和生活质量无显著差异。
腹腔静脉分流术使许多患者能够在院外成功接受治疗,适用于经过精心挑选的病例。